Your browser doesn't support javascript.
[Drug therapy interventions for acute SARS-CoV-2 infection: who, when, and what?] / Medikamentöse Therapiemaßnahmen bei akuter SARS-CoV-2-Infektion: wer, wann und was?
Dtsch Med Wochenschr ; 147(20): 1313-1320, 2022 10.
Article in German | MEDLINE | ID: covidwho-2050603
ABSTRACT
There is a variety of drug therapy options for treatment of acute SARS-CoV-2 infections. The updated S3 guideline "Recommendations for inpatient therapy of patients with COVID-19" provides clear recommendations in this regard. Which therapy is best suited for which patient and in which phase of the disease must be decided individually based on risk factors, comorbidities and contraindications. This article provides an overview.
Subject(s)

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Humans Language: German Journal: Dtsch Med Wochenschr Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Experimental Studies / Prognostic study Limits: Humans Language: German Journal: Dtsch Med Wochenschr Year: 2022 Document Type: Article